Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1

Texto completo
Autor(es):
Coitinho, Adriana S. ; Lopes, Marilene H. ; Hajj, Glaucia N. M. ; Rossato, Janine I. ; Freitas, Adriana R. ; Castro, Cibele C. ; Cammarota, Martin ; Brentani, Ricardo R. ; Izquierdo, Ivan ; Martins, Vilma R. [10]
Número total de Autores: 10
Tipo de documento: Artigo Científico
Fonte: Neurobiology of Disease; v. 26, n. 1, p. 282-290, Apr. 2007.
Área do conhecimento: Ciências Biológicas - Bioquímica
Assunto(s):Processos fisiológicos do sistema nervoso   Plasticidade neuronal   Proteínas   Príons
Resumo

Cellular prion protein (PrPC) is a cell surface glycoprotein that interacts with several ligands such as laminin, NCAM (Neural-Cell Adhesion Molecule) and the stress-inducible protein 1 (STI1). PrPC association with these proteins in neurons mediates adhesion, differentiation and protection against programmed cell death. Herein, we used an aversively motivated learning paradigm in rats to investigate whether STI1 interaction with PrPC affects short-term memory (STM) formation and long-term memory (LTM) consolidation. Blockage of PrPC-STI1 interaction with intra-hippocampal infusion of antibodies against PrPC or STI1 immediately after training impaired both STM and LTM. Furthermore, infusion of PrPC peptide 106-126, which competes for PrPC-STI1 interaction, also inhibited both forms of memory. Remarkably, STI1 peptide 230-245, which includes the PrPC binding site, had a potent enhancing effect on memory performance, which could be blocked by co-treatment with the competitive PrPC peptide 106-126. Taken together, these results demonstrate that PrPC-STI1 interaction modulates both STM and LTM and suggests a potential use of ST11 peptide 230-245 as a pharmacological agent. (AU)

Processo FAPESP: 03/13189-2 - Papel da proteína prion celular em processos fisiológicos e patológicos II
Beneficiário:Vilma Regina Martins
Linha de fomento: Auxílio à Pesquisa - Temático